Pharma
Times
Virupaksha Organics Ltd. has established itself as a trusted name in the global pharmaceutical market, specializing in the production of Fluconazole, a critical antifungal medication used to treat a wide range of fungal infections. With state-of-the-art manufacturing facilities located in Telangana, India, the company adheres to the highest standards of quality, safety, and regulatory compliance to produce high-purity Fluconazole for both domestic and international markets.
Fluconazole is widely prescribed to treat conditions like candidiasis and cryptococcal meningitis, and Virupaksha Organics’ commitment to producing this essential API ensures a reliable supply to healthcare providers worldwide. The company’s facilities are WHO-GMP, ISO 9001, and ISO 14001 certified, reflecting its dedication to maintaining excellence in manufacturing while also being environmentally conscious.
By leveraging cutting-edge technology and a robust research and development process, Virupaksha continues to meet the growing global demand for Fluconazole, ensuring that patients receive effective and affordable treatment. As part of its mission to be a research-driven pharmaceutical company, Virupaksha Organics remains a trusted partner for pharmaceutical companies around the globe, delivering high-quality APIs with a focus on customer satisfaction and sustainability.
With its expanding global footprint, Virupaksha Organics Ltd. is poised to remain at the forefront of the pharmaceutical industry, particularly in the production of vital medications like Fluconazole, helping to combat fungal infections and improve health outcomes worldwide.
Latest Update
- Mumbai: Kurla Landslide Death Toll 8; Search And Rescue Ends
- Trade Deficit Of $31.98 billion At Six-month High
- Jharkhand Exam Row: FIR Against 300 Unnamed People Over Assembly March
- Bengal: STF Scans Map, Photos Of Fort William Recovered From Pak National
- HC Quashes Darshan’s Plea Against Approver in Renukaswamy Murder Case
- India Pull Out of ASEAN Cup To Prioritise Brazil Friendly
- Panel’s Hospital Room Tariff Proposal Raises Questions Over Cost of Clinical Care
- India's Exports Surge 19.6% in July; Trade Deficit Widens To 6-Month High
- Kerala CM Faces Heat Over Youth Cong Member’s Drug Arrest, Meta Posts Removal
- Infantino Future Should Be Decided By Election, Says African Football Chief
- Emails Expose Indian Carmakers’ Fuel Contamination Concerns Before Public Retreat
- NHAI Sets 10-minute Deadline For Highway Ambulances, Rs 10,000 Penalty For Delay
- Putin Visits Japan-Claimed Pacific Islands, Drawing Tokyo’s Protest
- Chandrababu Naidu Inagurates Amaravati Seed Access Road, Connecting Steel Bridge
- Hilife Exhibitions’ Radiance Special August Brings 350+ Designers to Hyderabad
- Parliament session passes 12 bills but sees low productivity, says Kiren Rijiju
- SC questions Centre’s delay in front-of-pack warning labels for unhealthy foods
- Bengaluru accident: Woman dies after two-wheeler skids on Ananthanagar Main Road
- Raashii Khanna returns as Megha Vyas, begins shooting for Farzi 2
- NIMS Neurosurgeon Dr Thirumal Yerragunta selected as Scientist-in-Residence at UCF
- Junior NTR discharged from KIMS Hospitals after successful shoulder surgery
- AAIB fast-tracks probe into Air India Phuket-Delhi flight incident
- BikeWo, Hala Mobility sign MoU to deploy 1,000 EVs
- Mancherial police arrest 16 for cockfighting, seize 45 knives
- H-CITI works: Over 30% of flyovers, underpass completed in Gachibowli
- After Commonwealth Games gold, Sakshi Chaudhary targets Asian Games glory
- Narsapur police seize 350 quintals of PDS rice being transported to Maharashtra
- Forest officials express concern over remarks by MLAs Bojju, Harish Babu
- Modha Rathiri trailer promises a hilarious and meaningful wedding-night drama
- Gardner seeks privacy after personal controversy as CA backs her leadership